You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / ALKEM LABORATORIES

ALKEM LABORATORIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 0.1% , 1M : 3.6%,1Y : 33.5%
www.alkemlabs.com
BOM : 539523     NSE : ALKEM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Sep 17,2021
Price(EOD): Rs. 3,833.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
ALKEM LABORATORIES 0.1% 3.6% 33.5%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -1.8% 54.5%
DR REDDYS LABORATORIES -0.9% 4% 12.1%
DIVIS LABORATORIES 0.8% 4.4% 63.9%
CIPLA 0.4% 5.5% 31.5%
BIOCON 6.8% 2.9% -12.9%
AUROBINDO PHARMA 1.3% 2% -6%
LUPIN -3.4% -2.4% 0.1%
TORRENT PHARMACEUTICALS -0.9% 3% 9.7%


FUNDAMENTAL ANALYSIS OF ALKEM LABORATORIES

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than ALKEM LABORATORIES Plus/Pro


VALUATION OF ALKEM LABORATORIES

 
Valuation Score
[As on : Sep 17,2021 ]

Ratio Consolidated
P/E
P/B
P/S
28.91
P/E Calculated based on EPS of 132.58
[ Mar2021 - Consolidated Results ]

6.21
P/B Calculated based on Book Value of 616.95
[ Mar2021 - Consolidated Results ]

4.77
P/S Calculated based on Revenues of 9604.37 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than ALKEM LABORATORIES Plus/Pro


FAIR VALUE OF ALKEM LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
51%
-9%
-5%

SHARE PRICE MOMENTUM OF ALKEM LABORATORIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.18
0.19
0.09
0.15
0.23
0.26
0.17
0.22
[Last Annual Data : Mar2021]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
24.6%
103.66%
115.42%
92.69%
37.12%
13.64%
12.86%
13.48%
QtrlyTrend
8
Latest Qtr: Jun2021

ALKEM LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE LARGE MIDCAP 1.3% 6.3% 56.5%
S&P BSE 200 1.2% 6.4% 57.7%
S&P BSE 250 LARGEMIDCAP 1.2% 6.4% 58.2%
S&P BSE 150 MIDCAP 1.2% 6.4% 78.8%
S&P BSE ALLCAP 1.2% 6.3% 61.2%
S&P BSE 500 1.2% 6.4% 60%
S&P BSE MID CAP 1.1% 8.6% 72.8%
S&P BSE 400 MIDSMALLCAP 1% 6.2% 82.3%
S&P BSE MIDSMALLCAP 0.8% 7.5% 84%
S&P BSE HEALTHCARE -0.2% 1.3% 42.6%
S&P BSE LOW VOLATILITY -0.5% 5.1% 47.5%
NSE Indices1W1M1Y
NIFTY LARGE MIDCAP 250 1.3% 7% 65.9%
NIFTY 200 1.3% 6.6% 57.6%
NIFTY 100 1.2% 6.3% 54.7%
NIFTY 500 1.2% 6.5% 59.9%
NIFTY500 MULTICAP 50:25:25 1% 6.6% NA
NIFTY100 LOW VOLATILITY 30 1% 6.5% 49.6%
NIFTY ALPHA QTY LOW-VOLAT.30 0.9% 8.3% 50.1%
NIFTY QUALITY LOW-VOLATILTY 30 0.7% 7.3% 48.5%
NIFTY ALPHA QTY VAL LOW-VOL 30 0.6% 7.5% 50.1%
NIFTY NEXT 50 0.6% 8.6% 59.5%
NIFTY ALPHA LOW-VOLATILTY 30 0.2% 8.1% 51.8%
NIFTY PHARMA -0.2% 2.2% 28.1%
NIFTY HEALTHCARE -0.3% 1.2% NA

FAQ [Frequently Asked Questions]


Is ALKEM LABORATORIES good for long term investment?

As on 17-Sep-2021, the Fundamentals of ALKEM LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of ALKEM LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ALKEM LABORATORIES UnderValued or OverValued?

As on 17-Sep-2021, ALKEM LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of ALKEM LABORATORIES ?

As on 17-Sep-2021, the Intrinsic Value of ALKEM LABORATORIES is Rs. 4,046.45 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,537.72
Fair Value [Median EV / Sales Model] : Rs. 4,211.10
Fair Value [Median Price / Sales Model] : Rs. 4,046.45
Median Fair Value of ALKEM LABORATORIES : Rs. 4,046.45

Is ALKEM LABORATORIES trading at a Premium or Discount?

As on 17-Sep-2021, ALKEM LABORATORIES is trading at a Discount of -5% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of ALKEM LABORATORIES ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs DIVIS LABORATORIES LTD
CIPLA LTD vs BIOCON LTD vs AUROBINDO PHARMA LTD
LUPIN LTD vs TORRENT PHARMACEUTICALS LTD vs CADILA HEALTHCARE LTD
ABBOTT INDIA LTD vs ALKEM LABORATORIES LTD vs PIRAMAL ENTERPRISES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD vs IPCA LABORATORIES LTD vs PFIZER LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z